Literature DB >> 11085517

Up-regulation of clusterin during phthalocyanine 4 photodynamic therapy-mediated apoptosis of tumor cells and ablation of mouse skin tumors.

K Kalka1, N Ahmad, T Criswell, D Boothman, H Mukhtar.   

Abstract

Photodynamic therapy (PDT) using the silicon phthalocyanine photo-sensitizer Pc 4 is an oxidative stress associated with the induction of apoptosis in many cancer cells in vitro and in vivo. The mechanisms of PDT-induced tumor cell killing leading to apoptosis are incompletely understood. Clusterin, a widely expressed glycoprotein, is induced in tissues regressing as a consequence of oxidative stress-mediated cell death. Treatment of apoptosis-sensitive human epidermoid carcinoma cells (A431) with PDT resulted in significant up-regulation of clusterin with a maximum at 12 h after treatment, whereas clusterin levels in Pc 4-PDT-treated, apoptosis-resistant, radiation-induced fibrosarcoma (RIF-1) cells remained unchanged. The i.v. administration of Pc 4 to mice bearing chemically or UVB radiation-induced skin papillomas, followed by light application, led to increased clusterin protein expression, peaking 24 h after the treatment, when tumor regression was apparently visible. These data, for the first time, demonstrate the involvement of clusterin in PDT-mediated cell death and during tumor regression. This may have relevance in improving the efficacy of PDT using pharmacological inducers of clusterin.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11085517

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

Review 1.  Biomodulatory approaches to photodynamic therapy for solid tumors.

Authors:  Sanjay Anand; Bernhard J Ortel; Stephen P Pereira; Tayyaba Hasan; Edward V Maytin
Journal:  Cancer Lett       Date:  2012-07-25       Impact factor: 8.679

2.  Enhanced photodynamic efficacy towards melanoma cells by encapsulation of Pc4 in silica nanoparticles.

Authors:  Baozhong Zhao; Jun-Jie Yin; Piotr J Bilski; Colin F Chignell; Joan E Roberts; Yu-Ying He
Journal:  Toxicol Appl Pharmacol       Date:  2009-08-18       Impact factor: 4.219

3.  Clusterin facilitates COMMD1 and I-kappaB degradation to enhance NF-kappaB activity in prostate cancer cells.

Authors:  Amina Zoubeidi; Susan Ettinger; Eliana Beraldi; Boris Hadaschik; Anousheh Zardan; Leo W J Klomp; Colleen C Nelson; Paul S Rennie; Martin E Gleave
Journal:  Mol Cancer Res       Date:  2010-01-12       Impact factor: 5.852

4.  eIF3f reduces tumor growth by directly interrupting clusterin with anti-apoptotic property in cancer cells.

Authors:  Ji-Yeon Lee; Hyun-Ji Kim; Seung Bae Rho; Seung-Hoon Lee
Journal:  Oncotarget       Date:  2016-04-05

5.  Susceptibility of In Vitro Melanoma Skin Cancer to Photoactivated Hypericin versus Aluminium(III) Phthalocyanine Chloride Tetrasulphonate.

Authors:  I M Ndhundhuma; H Abrahamse
Journal:  Biomed Res Int       Date:  2017-09-25       Impact factor: 3.411

Review 6.  Oxidative Stress and Photodynamic Therapy of Skin Cancers: Mechanisms, Challenges and Promising Developments.

Authors:  Alessandro Allegra; Giovanni Pioggia; Alessandro Tonacci; Caterina Musolino; Sebastiano Gangemi
Journal:  Antioxidants (Basel)       Date:  2020-05-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.